Oral retinoid that selectively interacts with retinoid X receptors.

In early cutaneous T-cell disease stages IA-IIA response rate of greater than 50% associated monotherapy.

Adverse effects are hyperlipidemia, hypothyroidism, and less commonly leukopenia.

A selective retinoid X receptor modulator utilized for cutaneous T cell lymphoma.

Can selectively bind to alpha, beta, and gamma retinoid X receptors subtypes.

Leave a Reply

Your email address will not be published. Required fields are marked *